Akebia Therapeutics, Inc.

Abel Hall, LLC AKBA

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/17/2025

Shares

10,500

Value ($000)

29

Weight

0.0%

2025 Q2 - 2025 Q3 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/17/2025	29	0.0%	10,500	9/30/2025
2025 Q2	7/23/2025	39	0.0%	10,618	6/30/2025